Emerging paradigms in granulocyte-macrophage colony-stimulating factor signaling.
The myelomonocytic lineage of hematopoiesis is regulated by the growth factor granulocyte-macrophage colony-stimulating factor (GM-CSF). This cytokine has proven to be safe for use in coordination with the treatments for bone marrow transplants and acute myelogenous leukemia. GM-CSF and related cytokines operate through specific receptors in the membranes of target cells of the myelopoietic lineages (both immature and mature cells). The exact signal transduction mechanisms in the cell are only beginning to be clarified and involve a plethora of signaling molecules. With a wealth of new information from studies in GM-CSF-induced cell activation, three major experimental approaches are emerging as gold standards in the exploration of those signaling pathways initiated by hematopoietic growth factors. We consider here: (1) a protein-protein interaction, as exemplified by the association between the cytokine membrane receptor and JAK kinase; (2) a covalent modification of an enzyme, as studied in the phosphorylation of MAP kinase; and (3) a protein-DNA interaction, as demonstrated by the translocation of STAT from the cytosol to the nucleus where it can bind to the promoters of specific genes.
Gomez-Cambronero
J
J
Department of Physiology and Biophysics, Wright State University School of Medicine, Dayton, OH 45435, USA.
Veatch
C
C
D004268:DNA-Binding Proteins / Q000378:metabolism; D004789:Enzyme Activation; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000378:metabolism*; D006801:Humans; D010766:Phosphorylation; D011485:Protein Binding; D015398:Signal Transduction
D004268:DNA-Binding Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor